MicroRNA expression analysis of adult-onset drosophila Alzheimer’s disease model

Current Alzheimer Research

Volumn 11, Issue 9, 2014, Pages 882-891

  Kong, Yan ^a   Wu, Jianban ^a   Yuan, Liudi ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Adult onset; Alzheimer disease; Amino acid; Drosophila; Microarray; MicroRNA; Profiling

Indexed keywords

AMINOTRANSFERASE; ISOLEUCINE; JANUS KINASE; LEUCINE; MICRORNA; MICRORNA 1; MICRORNA 1017; MICRORNA 13B; MICRORNA 184; MICRORNA 193; MICRORNA 263B; MICRORNA 276A; MICRORNA 277; MICRORNA 279; MICRORNA 285; MICRORNA 289; MICRORNA 8; MICRORNA 981; MICRORNA 995; MICRORNA 9A; MITOGEN ACTIVATED PROTEIN KINASE; PROPIONIC ACID; PROTEIN LET 7; SPHINGOLIPID; STAT PROTEIN; UNCLASSIFIED DRUG; VALINE; MESSENGER RNA;

ADULT; ALZHEIMER DISEASE; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGRADATION; DROSOPHILA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MANIPULATION; GENETIC TRANSCRIPTION; MARKER GENE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOGENESIS; SIGNAL TRANSDUCTION; SPHINGOLIPID METABOLISM; UPREGULATION; ANIMAL; BRAIN; CELL LINE; CONDITIONED REFLEX; DISEASE MODEL; DROSOPHILA MELANOGASTER; ELECTRIC SHOCK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; GENETICS; LEARNING; METABOLISM; MOTOR ACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; SMELLING; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ASSOCIATION LEARNING; BRAIN; CELL LINE; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; ELECTROSHOCK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICROARRAY ANALYSIS; MICRORNAS; MOTOR ACTIVITY; OLFACTORY PERCEPTION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 84911454956     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666141001121416     Document Type: Article

References (55)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (9503): 2112-7 (2005).
2. Ittner LM, Gotz J. Amyloid-beta and tau--a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12 (2): 65-72 (2011).
3. Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10 (9): 698-712 (2011).
4. Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V, et al. Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 334 (6060): 1241-5 (2011).
5. Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92 (20): 9368-72 (1995).
6. Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, Duthie FA, et al. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132 (1): 123-35 (2005).
7. Lithner CU, Hedberg MM, Nordberg A. Transgenic mice as a model for Alzheimer's disease. Curr Alzheimer Res 8 (8): 818-31. (2011).
8. O'Hare E, Ardis T, Page D, Scopes DI, Kim EM. AbetaPPoverexpressing transgenic rat model of Alzheimer's disease utilizing the Tg2576 mouse protocol. J Alzheimer Dis 37 (1): 77-88 (2013).
9. Heuer E, Rosen RF, Cintron A, Walker LC. Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des 18 (8): 1159-69 (2012).
10. Schneider D. Using Drosophila as a model insect. Nat Rev Genet 1 (3): 218-26 (2000).
11. Bier E. Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6 (1): 9-23 (2005).
12. Luo L, Tully T, White K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9 (4): 595-605 (1992).
13. Greeve I, Kretzschmar D, Tschape JA, Beyn A, Brellinger C, Schweizer M, et al. Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J Neurosci 24 (16): 3899-906 (2004).
14. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci USA 101 (17): 6623-8 (2004).
15. Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C, et al. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet 6 (9): e1001087 (2010).
16. Rogers I, Kerr F, Martinez P, Hardy J, Lovestone S, Partridge L. Ageing increases vulnerability to abeta42 toxicity in Drosophila. PloS One 7 (7): e40569 (2012).
17. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 12 (12): 861-74 (2011).
18. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (1): 15-20 (2005).
19. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121 (2): 193-205 (2011).
20. Eacker SM, Dawson TM, Dawson VL. Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 10 (12): 837-41. (2009).
21. Long JM, Ray B, Lahiri DK. MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J Biol Chem 287 (37): 31298-310 (2012).
22. Long JM, Ray B, Lahiri DK. MicroRNA-339-5p down-regulates protein expression of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem 289 (8): 5184-98 (2014).
23. Wong HK, Veremeyko T, Patel N, Lemere CA, Walsh DM, Esau C, et al. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Hum Mol Genet 22 (15): 3077-92 (2013).
24. Bejarano F, Bortolamiol-Becet D, Dai Q, Sun K, Saj A, Chou YT, et al. A genome-wide transgenic resource for conditional expression of Drosophila microRNAs. Development 139 (15): 2821-31 (2012).
25. Chen YW, Weng R, Cohen SM. Protocols for use of homologous recombination gene targeting to produce microRNA mutants in Drosophila. Methods Mol Biol 732: 99-120 (2011).
26. Rival T, Soustelle L, Strambi C, Besson MT, Iche M, Birman S. Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr Biol 14 (7): 599-605 (2004).
27. Tully T, Quinn WG. Classical conditioning and retention in normal and mutant Drosophila melanogaster. J Comp Physiol A 157 (2): 263-77 (1985).
28. Zhou X, Zhu Q, Eicken C, Sheng N, Zhang X, Yang L, et al. MicroRNA profiling using microParaflo microfluidic array technology. Methods Mol Biol 822: 153-82 (2012).
29. Favrin G, Bean DM, Bilsland E, Boyer H, Fischer BE, Russell S, et al. Identification of novel modifiers of Abeta toxicity by transcriptomic analysis in the fruitfly. Sci Rep 3: 3512 (2013).
30. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 40 (Web Server issue): W498-504 (2012).
31. D'Aniello A, Fisher G, Migliaccio N, Cammisa G, D'Aniello E, Spinelli P. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients. Neurosci Lett 388 (1): 49-53 (2005).
32. Ibanez-Ventoso C, Vora M, Driscoll M. Sequence relationships among C. Elegans, D. melanogaster and human microRNAs highlight the extensive conservation of microRNAs in biology. PloS One 3 (7): e2818 (2008).
33. Liu CG, Song J, Zhang YQ, Wang PC. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease. Mol Med Rep [Epub ahead of print] (2014).
34. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimer Dis 39 (2): 253-9 (2014).
35. Chiang HC, Wang L, Xie Z, Yau A, Zhong Y. PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. P Proc Natl Acad Sci USA 107 (15): 7060-5 (2010).
36. Wang L, Chiang HC, Wu W, Liang B, Xie Z, Yao X, et al. Epidermal growth factor receptor is a preferred target for treating amyloid-beta-induced memory loss. Proc Natl Acad Sci USA 109 (41): 16743-8 (2012).
37. Hong YK, Lee S, Park SH, Lee JH, Han SY, Kim ST, et al. Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer's disease model. Biochem Biophys Res Commun 419 (1): 49-53 (2012).
38. Tan L, Schedl P, Song HJ, Garza D, Konsolaki M. The Toll-->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila. PloS One 3 (12): e3966 (2008).
39. Tsuda M, Kobayashi T, Matsuo T, Aigaki T. Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abetainduced neurotoxicity in Drosophila. FEBS Lett 584 (13): 2916-20 (2010).
40. Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, Chiang HC, et al. Overexpression of neprilysin reduces alzheimer amyloidbeta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive elementbinding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila. J Biol Chem 283 (27): 19066-76 (2008).
41. Lang M, Fan Q, Wang L, Zheng Y, Xiao G, Wang X, et al. Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Abeta42-induced Alzheimer's disease-like symptoms. Neurobiol Aging 34 (11): 2604-12 (2013).
42. Lang M, Wang L, Fan Q, Xiao G, Wang X, Zhong Y, et al. Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates abeta pathology in a Drosophila model of Alzheimer's disease. PLoS Genet 8 (4): e1002683 (2012).
43. Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, Liu B, et al. Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci 29 (7): 1335-47 (2009).
44. Caesar I, Jonson M, Nilsson KP, Thor S, Hammarstrom P. Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PloS One 7 (2): e31424 (2012).
45. Costa R, Speretta E, Crowther DC, Cardoso I. Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease. J Biol Chem 286 (48): 41647-55 (2011).
46. McKoy AF, Chen J, Schupbach T, Hecht MH. A novel inhibitor of amyloid beta (Abeta) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease. J Biol Chem 287 (46): 38992-9000 (2012).
47. Scherzer-Attali R, Pellarin R, Convertino M, Frydman-Marom A, Egoz-Matia N, Peled S, et al. Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. PloS One 5 (6): e11101 (2010).
48. Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med 14 (10): 1106-11 (2008).
49. Martinez M, Frank A, Diez-Tejedor E, Hernanz A. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. J Neural Transm Park Dis Dement Sect 6 (1): 1-9. (1993)
50. Hattori N, Abe K, Sakoda S, Sawada T. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease. Neuroreport 13 (1): 183-6 (2002).
51. Esslinger SM, Schwalb B, Helfer S, Michalik KM, Witte H, Maier KC, et al. Drosophila miR-277 controls branched-chain amino acid catabolism and affects lifespan. RNA Biol 10 (6): 1042-56 (2013).
52. Paik MJ, Cho IS, Mook-Jung I, Lee G, Kim KR. Altered free amino acid levels in brain cortex tissues of mice with Alzheimer's disease as their N (O,S)-ethoxycarbonyl/tert-butyldimethylsilyl derivatives. BMB Rep 41 (1): 23-8 (2008).
53. Morabito MV, Berman DE, Schneider RT, Zhang Y, Leibel RL, Small SA. Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease. Neurobio Dis 65: 188-92 (2014).
54. Piper MD, Blanc E, Leitao-Goncalves R, Yang M, He X, Linford NJ, et al. A holidic medium for Drosophila melanogaster. Nat Methods 11 (1): 100-5 (2014)
55. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466 (7308): 835-40 (2010).